Liver Cirrhosis: all 1,668 studies
Page 17 of 17. Open to participants first (360), then studies with results posted, then the rest; newest registration first within each.
- Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler IndicesCompletedNCT00466336
- Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation StudyCompletedNCT00466271
- Protein Biomarker in Hepatocellular CarcinomaTerminatedNCT00465842
- Screening of Fibrosing and/or Viral Chronic Hepatopathies in JailTerminatedNCT00453869
- Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical TrialCompletedNCT00420134Phase 1/2
- Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary CirrhosisCompletedNCT00406237Phase 1
- Stem Cell Transplantation in Patients With Primary Biliary CirrhosisWithdrawnNCT00393185Phase 1
- Safety Study of Autologous Stem Cell in Liver CirrhosisTerminatedNCT00382278Phase 1/2
- Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)WithdrawnNCT00381017Phase 3
- Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in CirrhoticsTerminatedNCT00375011
- Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the LiverTerminatedNCT00366795Phase 3
- Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial PeritonitisCompletedNCT00359853Phase 4
- Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the LiverTerminatedNCT00359437Phase 3
- Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)CompletedNCT00358878Phase 3
- Phase 1 Study of L-NMMA in Patients With Liver CirrhosisCompletedNCT00344916Phase 1
- Echocardiographic Assessment of Intrapulmonary Vasodilatation: Agitated Saline Versus PolygelineStatus unknownNCT00343122
- Banding Versus Propranolol for Primary Prophylaxis of Variceal BleedingTerminatedNCT00337740Phase 3
- Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver CirrhosisStatus unknownNCT00332904Phase 4
- Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral TherapyCompletedNCT00326482
- Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.CompletedNCT00323804Phase 2/3
- Probiotics for the Prevention of Major Complications of CirrhosisCompletedNCT00312910Not applicable
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)CompletedNCT00304551Phase 3
- Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) CirrhosisCompletedNCT00301509Phase 2/3
- Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis CCompletedNCT00298714Phase 4
- Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs AlbuminSuspendedNCT00287664Phase 4
- Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)CompletedNCT00287235Not applicable
- The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic EncephalopathyStatus unknownNCT00281502Phase 2
- A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.CompletedNCT00275652Phase 3
- Treatment With IFN After Curative Resection of HCC in HCV-Related CirrhosisCompletedNCT00273247Phase 3
- Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis CCompletedNCT00252642Not applicable
- DOCICAR: Cardiac Dysfunction in CirrhosisCompletedNCT00250315
- Ischemic Preconditioning of Liver in Cadaver DonorsCompletedNCT00245830Not applicable
- Indocyangreen Elimination in Cirrhosis and Acute Liver FailureCompletedNCT00245310
- Development of a Breath Test for Monitoring Patients With Liver DiseaseCompletedNCT00244569Phase 3
- Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS)CompletedNCT00243633Not applicable
- Family Studies in Primary Biliary Cirrhosis (PBC)Status unknownNCT00242125
- Prevention of Decompensation in Liver CirrhosisStatus unknownNCT00239096Phase 4
- PiCCO Guided Therapy in Liver CirrhosisCompletedNCT00232427Not applicable
- TIPS With Coated Stents for Refractory Ascites in Patients With CirrhosisCompletedNCT00222014Not applicable
- Selenium Supplementation of Patients With CirrhosisTerminatedNCT00212212Not applicable
- Selenium Supplementation of Patients With CirrhosisCompletedNCT00212186Not applicable
- Screening of Hepatocellular Carcinoma in Patients With Compensated CirrhosisCompletedNCT00190385Phase 3
- Diagnosis of Variceal Bleeding and Its Control in CirrhosisTerminatedNCT00188097Not applicable
- Enteral Nutrition in Liver CirrhosisCompletedNCT00168961Phase 4
- Urotensin II and Vascular Tone in CirrhosisStatus unknownNCT00163995
- Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic CirrhosisCompletedNCT00163631
- Clinical Trial of Pentoxifylline in Patient With CirrhosisCompletedNCT00162552Phase 3
- Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral HepatitisStatus unknownNCT00160940
- Use of NovoSeven® in Active Variceal BleedingCompletedNCT00154492Phase 2
- Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver CancerTerminatedNCT00151671Phase 2/3
- Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)Status unknownNCT00145964
- SAMe to Treat Biliary Cirrhosis SymptomsTerminatedNCT00125281Phase 2
- Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial PeritonitisCompletedNCT00124228Phase 3
- Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis CCompletedNCT00122616Phase 3
- Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis CTerminatedNCT00119119Phase 3
- Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and AscitesCompletedNCT00115947Phase 2/3
- Treatment of Cholestatic Pruritus With SertralineCompletedNCT00058903Phase 2
- Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or CirrhosisCompletedNCT00043303Phase 2
- Prevention of Esophageal Varices by Beta-Adrenergic BlockersCompletedNCT00006398Phase 3
- Ursodiol-Methotrexate for Primary Biliary CirrhosisCompletedNCT00006168Phase 3
- North American Study for the Treatment of Refractory Ascites (NASTRA)CompletedNCT00006166Phase 3
- Decompression Intervention of Variceal Rebleeding Trial (DIVERT)CompletedNCT00006161Phase 3
- Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and EndotoxemiaStatus unknownNCT00005107Phase 1
- Pilot Study of Budesonide for Patients With Primary Sclerosing CholangitisCompletedNCT00004842Phase 1
- Phase II Study of Lactulose and Circadian Rhythms in Patients With CirrhosisCompletedNCT00004796Phase 2
- Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary CirrhosisCompletedNCT00004784Phase 3
- Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary CirrhosisCompletedNCT00004748Phase 3
- Phase I Study of Colchicine Therapy in Childhood Hepatic CirrhosisStatus unknownNCT00004368Phase 1